We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Fast, Cost-Effective Technique Developed for Finding Gene "On-Off” Switches

By LabMedica International staff writers
Posted on 08 Jun 2009
Scientists have created a tool for rapidly identifying large numbers of the genetic material known as short hairpin RNA (shRNA) that turns genes on and off. More...


The method, which the research team has used to create a library of 22,000 of these "on-off” switches for approximately 600 human genes, provides a tool for scientists worldwide, with ultimate impacts on the study of the genetic basis of diseases ranging from HIV to high cholesterol, Parkinson's disease, or cancer. The scientists, from the University of California, San Francisco (UCSF; USA), are currently working on creating an shRNA library for the entire human genome. Findings are available in the advanced online publication section of the journal Nature Methods in May 2009 and will appear later in the print issue of the journal.

Since their discovery in the past 10 years, biologically active small RNAs have become the holy grail of much pharmaceutical and genomics research, offering the potential of creating targeted therapeutics to "turn off” or turn down the "volume” of various genes involved in disease, according to Michael McManus, Ph.D., a UCSF microbiology professor and senior author on the study. This process is known as RNA interference.

Until now, however, the process of finding shRNAs that are able to potently deactivate a given gene has been extremely labor-intensive and laden with many false results. The new method uses a microarray technology to generate large numbers of these shRNA strands for each target gene--approximately 10 times the volume of traditional methods--thereby enabling researchers to screen for RNA interference much faster than before and at a minimal cost, according to Dr. McManus. "This means that even a small laboratory with limited resources can perform complex genetic screens on mammalian cell cultures,” he said. "With the current scarcity of research funding, these are invaluable tools for researchers worldwide.”

Many diseases already have been linked to specific genes that are mutated or turned on to cause the illness. How those genes actually cause the illness is less clear, but by using shRNA to turn the genes off, researchers can study specific genetic function and start to identify drugs or therapeutics to change it. The system, which uses deep sequencing technology to rapidly uncover effective shRNAs by simultaneously sequencing millions of base pairs of DNA, also enables scientists to better identify which of those tiny RNA-strands is most effective in turning off a particular gene and which ones are effective but also cause side effects on untargeted genes.

Research into gene function has been done for years with worms and fruit flies, whose short life spans and rapid reproduction make genetic testing relatively inexpensive, Dr. McManus reported. But in mammals, studying the function of individual genes can often cost a laboratory US$100,000 or more in basic materials and require complex technology to run.

The UCSF shRNA library aims to offer more than 600,000 different samples of shRNA-- about 30 for every human gene. Once the shRNA library is complete for the human genome, the team will continue creating libraries for other species.

According to Dr. McManus, he plans to make shRNA libraries available through the UCSF Sandler Lentiviral RNAi Core, which he directs. The Core provides essential equipment, training, supervision, and monitoring for researchers working in lentiviral-based research, as well as offering viral packaging and other services for researchers.

Related Links:

University of California, San Francisco





Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Human Estradiol Assay
Human Estradiol CLIA Kit
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.